Galapagos NV. announced its plans to split into two listed entities by mid-2025 by spinning off its activities focused on ...

In a report released today, Judah Frommer from Morgan Stanley maintained a Hold rating on Galapagos (GLPG – Research Report), with a price ...

Galapagos NV (NASDAQ:GLPG – Get Free Report) has received an average recommendation of “Reduce” from the eight research firms ...

Belgium-based biotech company Galapagos NV's (GLPG) U.S.-listed shares rose over 4% in Wednesday's premarket after it announced a significant restructuring plan, including a spin-off into two ...

Fintel reports that on January 23, 2025, Barclays downgraded their outlook for Galapagos NV - Depositary Receipt () (NasdaqGS:GLPG) from Equal-Weight to Underweight. Analyst Price Forecast Suggests 48 ...

Galapagos (0JXZ – Research Report) received a Sell rating and a €22.00 price target from Barclays analyst Emily Field today. The company’s ...

Belgian biotech company Galapagos NV plans to spin off part of its operations, creating a new listed firm with approximately €2.45 billion ($2.5 billion) in cash. The newly formed company ...

MECHELEN, Belgium – January 8, 2025 – 07:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) (“Galapagos” or the ...

Galapagos NV has a twelve month low of $23.45 and a twelve month high of $40.34. The business’s 50-day moving average price is $26.55 and its two-hundred day moving average price is $27.41 ...

Mechelen, Belgium; January 7, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company will present at the 43 rd Annual J.P. Morgan Healthcare Conference on ...

A diver's journey to the Galapagos Islands aboard a small expedition ship. Diving with sharks, turtles, sea lions, rays and ...